- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/60 - Three or more oxygen or sulfur atoms
Patent holdings for IPC class C07D 239/60
Total number of patents in this class: 92
10-year publication summary
|
7
|
12
|
7
|
5
|
12
|
3
|
3
|
5
|
6
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 1470 |
7 |
| Bristol-myers Squibb Company | 4815 |
4 |
| Glaxosmithkline LLC | 529 |
3 |
| Shionogi & Co., Ltd. | 867 |
3 |
| Inflazome Limited | 84 |
3 |
| Acquist LLC | 11 |
3 |
| Carbocode S.A. | 37 |
3 |
| FUJIFILM Corporation | 30296 |
2 |
| Takeda Pharmaceutical Company Limited | 2716 |
2 |
| Arizona Board of Regents on behalf of Arizona State University | 2864 |
2 |
| Changzhou University | 205 |
2 |
| Memorial Sloan-Kettering Cancer Center | 2008 |
2 |
| Nektar Therapeutics | 422 |
2 |
| Teva Pharmaceuticals International GmbH | 314 |
2 |
| Zhejiang University | 3372 |
2 |
| Nuhope LLC | 3 |
2 |
| Septerna, Inc. | 18 |
2 |
| Merck Patent GmbH | 5669 |
1 |
| Toray Industries, Inc. | 7053 |
1 |
| Korea Institute of Science and Technology | 2206 |
1 |
| Other owners | 43 |